Vincerx Pharma Inc. (VINC:NASDAQ) shot up at $1.08, representing a gain of 58.8%. On Tue, Dec 13, 2022, VINC:NASDAQ hit a New 2-Week High of $1.08. The stock got featured on our News Catalysts scanner on Tue, Dec 13, 2022 at 10:34 AM in the 'BIOTECH' category. From Tue, Nov 29, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Oct 12, 2022 at $1.56 with a volume of 1M+.
About Vincerx Pharma Inc. (VINC:NASDAQ)
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of...
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- OpGen, Inc. (OPGN:NASDAQ), 84.8%
- Vincerx Pharma Inc. (VINC:NASDAQ), 58.82%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 52.78%
- Shineco Inc. (SISI:NASDAQ), 49.23%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 43.8%
- Summit Therapeutics plc (SMMT:NASDAQ), 38.65%
- BeyondSpring Inc. (BYSI:NASDAQ), 35.94%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 33.83%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 32.69%